Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy
Authors
Keywords
-
Journal
JAMA Oncology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-01-21
DOI
10.1001/jamaoncol.2021.6416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
- (2021) Sue S. Yom et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome
- (2020) Sarah Deschuymer et al. RADIOTHERAPY AND ONCOLOGY
- Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer
- (2020) David J. Sher et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma
- (2019) Daniel J. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
- (2019) Bhishamjit S. Chera et al. JOURNAL OF CLINICAL ONCOLOGY
- OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
- (2018) T Y Seiwert et al. ANNALS OF ONCOLOGY
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
- (2017) Shanthi Marur et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
- (2017) Allen M Chen et al. LANCET ONCOLOGY
- Recurrence patterns after a decreased dose of 40 Gy to the elective treated neck in head and neck cancer
- (2017) Daan Nevens et al. RADIOTHERAPY AND ONCOLOGY
- Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT
- (2016) Stanley Gutiontov et al. ORAL ONCOLOGY
- Unknown
- (2016) CANCER
- Sparing Bilateral Neck Level IB in Oropharyngeal Carcinoma and Xerostomia Outcomes
- (2015) Moses Tam et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance
- (2015) Pranshu Mohindra et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Unknown
- (2015) LARYNGOSCOPE
- HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V
- (2013) Giuseppe Sanguineti et al. ACTA ONCOLOGICA
- HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity
- (2013) Thorsten Rieckmann et al. RADIOTHERAPY AND ONCOLOGY
- Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy
- (2012) Adam S. Garden et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35
- (2012) Pia López-Jornet et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial
- (2012) Jean Bourhis et al. LANCET ONCOLOGY
- Development and validation of the Gothenburg Trismus Questionnaire (GTQ)
- (2012) Joakim Johnson et al. ORAL ONCOLOGY
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Dose–Volume Effects in the Larynx and Pharynx
- (2010) Tiziana Rancati et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy Dose–Volume Effects on Salivary Gland Function
- (2010) Joseph O. Deasy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the Risk of Involvement for Each Neck Nodal Level in Patients With Early T-Stage Node-Positive Oropharyngeal Carcinoma
- (2009) Giuseppe Sanguineti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure
- (2009) Megan E. Daly et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now